JP2024529506A5 - - Google Patents

Info

Publication number
JP2024529506A5
JP2024529506A5 JP2024505498A JP2024505498A JP2024529506A5 JP 2024529506 A5 JP2024529506 A5 JP 2024529506A5 JP 2024505498 A JP2024505498 A JP 2024505498A JP 2024505498 A JP2024505498 A JP 2024505498A JP 2024529506 A5 JP2024529506 A5 JP 2024529506A5
Authority
JP
Japan
Prior art keywords
substituted
seq
sequence
chain
nectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038720 external-priority patent/WO2023009751A2/en
Publication of JP2024529506A publication Critical patent/JP2024529506A/ja
Publication of JP2024529506A5 publication Critical patent/JP2024529506A5/ja
Pending legal-status Critical Current

Links

JP2024505498A 2021-07-30 2022-07-28 ネクチン-4に特異的な抗体および抗体複合体、並びにそれらの使用方法 Pending JP2024529506A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163227666P 2021-07-30 2021-07-30
US63/227,666 2021-07-30
US202263322914P 2022-03-23 2022-03-23
US63/322,914 2022-03-23
US202263344932P 2022-05-23 2022-05-23
US63/344,932 2022-05-23
PCT/US2022/038720 WO2023009751A2 (en) 2021-07-30 2022-07-28 Antibodies and antibody conjugates specific for nectin-4 and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024529506A JP2024529506A (ja) 2024-08-06
JP2024529506A5 true JP2024529506A5 (cg-RX-API-DMAC10.html) 2025-10-15

Family

ID=85088249

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024505498A Pending JP2024529506A (ja) 2021-07-30 2022-07-28 ネクチン-4に特異的な抗体および抗体複合体、並びにそれらの使用方法
JP2024505116A Pending JP2024529466A (ja) 2021-07-30 2022-07-28 抗体薬物コンジュゲート及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024505116A Pending JP2024529466A (ja) 2021-07-30 2022-07-28 抗体薬物コンジュゲート及びその使用方法

Country Status (9)

Country Link
US (2) US20250121090A1 (cg-RX-API-DMAC10.html)
EP (3) EP4377320A4 (cg-RX-API-DMAC10.html)
JP (2) JP2024529506A (cg-RX-API-DMAC10.html)
KR (2) KR20240040098A (cg-RX-API-DMAC10.html)
AU (2) AU2022319782A1 (cg-RX-API-DMAC10.html)
CA (2) CA3227845A1 (cg-RX-API-DMAC10.html)
IL (1) IL310432A (cg-RX-API-DMAC10.html)
MX (2) MX2024001396A (cg-RX-API-DMAC10.html)
WO (3) WO2023009751A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법
KR20250161707A (ko) * 2024-05-08 2025-11-18 아주대학교산학협력단 Nectin-2에 결합하는 항체 약물 접합체 및 이의 용도
WO2026039627A1 (en) * 2024-08-16 2026-02-19 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2682449C2 (ru) * 2012-09-19 2019-03-19 Иннейт Фарма Связывающие kir3dl2 агенты
US9310374B2 (en) * 2012-11-16 2016-04-12 Redwood Bioscience, Inc. Hydrazinyl-indole compounds and methods for producing a conjugate
CN115504924A (zh) * 2013-11-27 2022-12-23 雷德伍德生物科技股份有限公司 肼基-吡咯并化合物及用于生成缀合物的方法
WO2017083306A1 (en) * 2015-11-09 2017-05-18 R.P. Scherer Technologies, Llc Anti-cd22 antibody-maytansine conjugates and methods of use thereof
RU2746413C1 (ru) * 2017-03-21 2021-04-13 Пептрон, Инк. Антитело, специфически связывающееся с muc1, и его применение
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof
MX2020006010A (es) * 2017-12-11 2020-10-16 Triphase Res And Development Iii Corp Conjugados de anticuerpo anti-cd22-maitansina, combinaciones y metodos de uso de los mismos.
AU2019206207B2 (en) * 2018-01-15 2025-04-10 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
US12077583B2 (en) * 2018-05-09 2024-09-03 Nectin Therapeutics Ltd. Antibodies specific to human NECTIN4
WO2020154437A1 (en) * 2019-01-23 2020-07-30 R.P. Scherer Technologies, Llc Glycoside-containing peptide linkers for antibody-drug conjugates
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법

Similar Documents

Publication Publication Date Title
JP7854016B2 (ja) 腫瘍治療薬及びその応用
JP2022065174A5 (cg-RX-API-DMAC10.html)
JP2022064924A5 (cg-RX-API-DMAC10.html)
JP2022506072A5 (cg-RX-API-DMAC10.html)
EP2552959B1 (en) Antibodies to muc16 and methods of use thereof
CN113301920B (zh) 包含配体、间隔物、肽接头和生物分子的复合物
JP2018502050A5 (cg-RX-API-DMAC10.html)
DK2678037T3 (en) Branched linker for protein pharmaceutical conjugates
TW201918263A (zh) 抗體-藥物結合物之改良製造方法
AU2017320913A1 (en) Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
JP2021524270A5 (cg-RX-API-DMAC10.html)
KR20220151630A (ko) 신규 고리형 디뉴클레오티드 유도체를 포함하는 항체 약물 컨쥬게이트
JP7360766B2 (ja) 抗ヒトMUC1抗体Fabフラグメント、ペプチドリンカー及び/又は配位子を含む複合体
JP2017509594A5 (cg-RX-API-DMAC10.html)
IL293095A (en) Directed conjugation technologies
WO2023168384A2 (en) Methods of treating cancer using multi-specific binding proteins that bind nkg2d, cd16, and her2
WO2022180581A2 (en) Anti-her2 antibody-drug conjugates and uses thereof
CA3237844A1 (en) Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereof
JPWO2020032165A1 (ja) ビオチン改変二量体とフタロシアニン染料とのコンジュゲート
AU2022234694A1 (en) Compound or salt thereof, and antibody obtained using same
WO2025060979A1 (zh) 一种靶向PD-L1的γδT细胞及其制备方法与应用
CN115916839A (zh) 抗pdl1×egfr的双特异性抗体
JP2024529466A5 (cg-RX-API-DMAC10.html)
WO2024160176A1 (zh) 一类连接子药物及其抗体-药物偶联物的制备方法和应用
KR102495650B1 (ko) 알데히드 함유 표적 분자의 라벨링 방법